Immucor is out for blood that is testing blood for antibodies and other serum components prior to transfusions. With its acquisition of Gamma Biologicals and Biopool International in the past decade, this market leader in blood testing systems sales has had a 2,893% rate of return. Rising stock prices from $1.14 in 97 to $33.39 in 07 has been a result of its worldwide expansion. Their recent double-digit sales growth is generating investor interest today. A covered call investing position for BLUD is currently available for August stock options expiration with a potential return of...
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.
With the market acting a little more reasonable today, I wanted to find a stock that fit my criteria that I could share with all of you. Going to my usual 'first step' in identifying stocks, I noted that Immucor (BLUD) had made the list of top % gainers on the Nasdaq to
this stock is within $4.00 of its low of $26.00, it follows the market up and downs pretty close its a safe bet if the market does not pick up it may fall below $26. this will recover earnings per share have steadyly increased over the last year
this stock is within $4.00 of its low of $26.00, it follows the market up and downs pretty close its a safe bet if the market does not pick up it may fall below $26. this will recover earnings per share have steadyly increased over the last year
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.
A few moments ago my Immucor (BLUD) stock hit a sale point at an (8)% loss. I sold 154 shares at $34.90. These shares were purchased only a couple of weeks ago, on October 4, 2007, at a cost basis of $38.02. Thus, I had a loss of $(3.12)/share or (8.2)% since purchase.
Even if the national headlines weren't already providing enough focus on the economy, plenty of economic data is due out as the month and the quarter wind down. U.S. economic data scheduled to be released this week include:
Gross margins are expected to regain momentum from the eventual growth in reagent sales, manufacturing efficiencies, and price increases. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experime...
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob’s Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.
One of my favorite activities as author of this blog is to receive, read, and respond to email and comments regarding investing. I hope through these discussions that I have helped others understand investing concepts as much as I learn from these questions as well.
Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website.
One of my favorite activities as author of this blog is to receive, read, and respond to email and comments regarding investing. I hope through these discussions that I have helped others understand investing concepts as much as I learn from these questions as well.
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.